Abliva AB
Company Profile
Business description
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase. . The company is focused on two projects. KL1333, a powerful NAD+ and NADH regulator, in late-stage development and has been granted orphan drug designation in Europe and the US. NV354, an energy replacement therapy, has just completed preclinical development.
Contact
Scheeletorget 1
Medicon Village
Lund 223 81
SWET: +46 462756220
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
6
Stocks News & Analysis
stocks
3 shares with high dividend yields from our Global Best Ideas list
video
Our view of mining shares
stocks
Undervalued ASX share with robust cash flow
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,208.60 | 42.20 | 0.52% |
| CAC 40 | 7,608.77 | 13.25 | -0.17% |
| DAX 40 | 18,566.68 | 159.61 | 0.87% |
| Dow JONES (US) | 40,415.44 | 127.91 | 0.32% |
| FTSE 100 | 8,177.07 | 21.71 | -0.26% |
| HKSE | 17,469.36 | 166.52 | -0.94% |
| NASDAQ | 18,007.57 | 280.63 | 1.58% |
| Nikkei 225 | 39,594.39 | 4.61 | -0.01% |
| NZX 50 Index | 12,425.58 | 115.67 | 0.94% |
| S&P 500 | 5,564.41 | 0.00 | 0.00% |
| S&P/ASX 200 | 7,971.10 | 39.40 | 0.50% |
| SSE Composite Index | 2,915.37 | 48.85 | -1.65% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Alumina Ltd AWC | 1.45 | 0.03 | -1.69% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 1.42 | 0.13 | -8.39% |
| Zip Co Ltd ZIP | 1.80 | 0.11 | 6.19% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -2.00% |
| South32 Ltd S32 | 2.98 | 0.01 | -0.33% |
| Spartan Resources Ltd SPR | 1.23 | 0.24 | 23.62% |
| Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.06 | 0.00 | 7.14% |
| Mesoblast Ltd MSB | 1.31 | 0.15 | 12.99% |